Abstract
Several plant medicines are presented that have not been previously discussed in detail and are used in China and the USA for the management of Alzheimer’s disease. These plant medicines may provide new leads for drug therapy of this disease. Prevention of Alzheimer’s disease is presented as potentially the best way to manage the disease.
Keywords: Alzheimer’s disease, prevention, plant medicine.
Letters in Drug Design & Discovery
Title:Alzheimer's Disease Prevention and Use of Traditional Plant Medicines
Volume: 12 Issue: 2
Author(s): Xiaogang Wang, Raphael Dubois and James David Adams Jr
Affiliation:
Keywords: Alzheimer’s disease, prevention, plant medicine.
Abstract: Several plant medicines are presented that have not been previously discussed in detail and are used in China and the USA for the management of Alzheimer’s disease. These plant medicines may provide new leads for drug therapy of this disease. Prevention of Alzheimer’s disease is presented as potentially the best way to manage the disease.
Export Options
About this article
Cite this article as:
Wang Xiaogang, Dubois Raphael and Jr David Adams James, Alzheimer's Disease Prevention and Use of Traditional Plant Medicines, Letters in Drug Design & Discovery 2015; 12 (2) . https://dx.doi.org/10.2174/1570180811666140819223819
DOI https://dx.doi.org/10.2174/1570180811666140819223819 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Side Effects of Atypical Antipsychotic Drugs
Current Pharmaceutical Design Patent Selections
Recent Patents on Biotechnology Global Cerebral Ischemia: Synaptic and Cognitive Dysfunction
Current Drug Targets Matrix Metalloproteinases: Drug Targets for Myocardial Infarction
Current Drug Targets Phytotherapy for the Prevention of Atherosclerosis-Associated Early Cerebral Ischemia
Current Drug Metabolism Characterizing the Binding of Angiotensin Converting Enzyme I Inhibitory Peptide to Human Hemoglobin: Influence of Electromagnetic Fields
Protein & Peptide Letters ESVS Guidelines: Section A - Prevention in Patients with Carotid Stenosis
Current Vascular Pharmacology New Oral Anticoagulants in Coronary Artery Disease
Cardiovascular & Hematological Disorders-Drug Targets New Agents – Manifold Consequences: The Management of Lung and Colorectal Cancer is Changing
Current Cancer Therapy Reviews Transcatheter Aortic Valve Implantation versus Surgical Aortic Valve Replacement: Meta-Analysis of Clinical Outcomes and Cost-Effectiveness
Current Pharmaceutical Design Chemokines and Atherosclerotic Plaque Progression: Towards Therapeutic Targeting?
Current Pharmaceutical Design Cancer Therapeutics-Related Cardiovascular Complications. Mechanisms, Diagnosis and Treatment
Current Pharmaceutical Design Clinical Applicability of Conditioning Techniques in Ischemia-Reperfusion Injury: A Review of the Literature
Current Cardiology Reviews Subject Index To Volume 12
Current Pharmaceutical Design Pharmacological Therapies for Pediatric and Neonatal ALI/ARDS: An Evidence-Based Review
Current Drug Targets Novel Anticoagulants vs Warfarin for Stroke Prevention in Atrial Fibrillation
Cardiovascular & Hematological Disorders-Drug Targets The Spatial QRS-T Angle: Implications in Clinical Practice
Current Cardiology Reviews Cholesterol Ester Transfer Protein (CETP), Postprandial Lipemia and Hypolipidemic Drugs
Current Medicinal Chemistry Overview
Mini-Reviews in Medicinal Chemistry Pleiotropic Actions of PPARg Activators Thiazolidinediones in Cardiovascular Diseases
Current Pharmaceutical Design